These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22611031)

  • 1. Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.
    Blomstrand M; Brodin NP; Munck Af Rosenschöld P; Vogelius IR; Sánchez Merino G; Kiil-Berthlesen A; Blomgren K; Lannering B; Bentzen SM; Björk-Eriksson T
    Neuro Oncol; 2012 Jul; 14(7):882-9. PubMed ID: 22611031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing.
    Baliga S; Adams JA; Bajaj BVM; Van Benthuysen L; Daartz J; Gallotto SL; Lewy JR; DeNunzio N; Weyman EA; Lawell MP; Palmer JD; Yeap BY; Ebb DH; Huang MS; Perry AF; MacDonald SM; Jones RM; Tarbell NJ; Yock TI
    Cancer; 2023 Mar; 129(5):764-770. PubMed ID: 36504293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated arc therapy for pediatric posterior fossa tumors.
    Beltran C; Gray J; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e299-304. PubMed ID: 21570213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.
    Brodin NP; Munck af Rosenschöld P; Blomstrand M; Kiil-Berthlesen A; Hollensen C; Vogelius IR; Lannering B; Bentzen SM; Björk-Eriksson T
    Neuro Oncol; 2014 Apr; 16(4):594-602. PubMed ID: 24327585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of Craniospinal Irradiation for Pediatric Medulloblastoma Using VMAT and IMRT.
    Al-Wassia RK; Ghassal NM; Naga A; Awad NA; Bahadur YA; Constantinescu C
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e405-11. PubMed ID: 26334433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
    Beltran C; Roca M; Merchant TE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
    Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
    Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
    Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
    Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal normal tissue sparing in craniospinal axis irradiation using IMRT with daily intrafractionally modulated junction(s).
    Kusters JM; Louwe RJ; van Kollenburg PG; Kunze-Busch MC; Gidding CE; van Lindert EJ; Kaanders JH; Janssens GO
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1405-14. PubMed ID: 21300472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of multiple isocentric volumetric modulated arc therapy technique for craniospinal axis radiotherapy planning.
    Lee YK; Brooks CJ; Bedford JL; Warrington AP; Saran FH
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1006-12. PubMed ID: 21345612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks.
    Parker W; Filion E; Roberge D; Freeman CR
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):251-7. PubMed ID: 17707279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy.
    Sharma DS; Gupta T; Jalali R; Master Z; Phurailatpam RD; Sarin R
    Br J Radiol; 2009 Dec; 82(984):1000-9. PubMed ID: 19581313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.
    Brodin NP; Vogelius IR; Björk-Eriksson T; Munck Af Rosenschöld P; Maraldo MV; Aznar MC; Specht L; Bentzen SM
    Acta Oncol; 2014 Apr; 53(4):462-70. PubMed ID: 24274390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of radiation-induced neurocognitive impairment and the impact of sparing the hippocampus during pediatric proton cranial irradiation.
    Gram D; Brodin NP; Björk-Eriksson T; Nysom K; Munck Af Rosenschöld P
    Acta Oncol; 2023 Feb; 62(2):134-140. PubMed ID: 36847433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
    Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
    Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
    Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
    Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.